Fibronectin overexpression in retinal microvessels of patients with diabetes

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 2, 1996, Pages 258-266

  Roy, Sayon ^a   Cagliero, Enrico ^a   Lorenzi, Mara ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

basement membrane; cell adhesion; diabetic retinopathy; fibronectin

Indexed keywords

FIBRONECTIN; MESSENGER RNA;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BASE SEQUENCE; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; DNA PRIMERS; FEMALE; FIBRONECTINS; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RETINA; RETINAL VESSELS; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE;

EID: 0030019991     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Osterby R. Basement membrane morphology in diabetes mellitus. In: Rifkin H, Porte D Jr, eds. Diabetes Mellitus: Theory and Practice. New York: Elsevier; 1990:220-233.
2. Martinez-Hernandez A, Amenta PS. The basement membrane in pathology. Lab Invest. 1983;48:656-677.
3. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high glucose-induced overexpression of basement membrane components in cultured endothelial cells. Diabetes. 1991;40:102-110.
4. Ayo SH, Radnik RA, Glass II WF, et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol. 1991;260:F185-F191.
5. Mandarino LJ, Sundarraj N, Finlayson J, Hassell JR. Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro. Exp Eye Res. 1993;57:609-621.
6. von der Mark K, von der Mark H, Goodman S. Cellular responses to extracellular matrix. Kidney Int. 1992;41:632-640.
7. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
8. Vuorio E, de Crombugghe B. The family of collagen genes. Annu Rev Biochem. 1990;59:837-872.
9. Roy S, Maiello M, Lorenzi M. Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest. 1994;93:438-442.
10. Laurie GW, Leblond CP, Martin GR. Localization of type IV collagen, laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes. J Cell Biol 1982;95:340-344.
11. Canfield AE, Schor AM, Loskuloff DJ, Schor SL, Grant ME. Plasminogen activator inhibitor-type 1 is a major biosynthetic product of retinal microvascular endothelial cells and pericytes in culture. Biochem J. 1989;259:529-535.
12. Essner E, Lin WL. Immunocytochemical localization of laminin, type IV collagen, and fibronectin in rat retinal vessels. Exp Eye Res. 1988;47:317-327.
13. Jerdan JA, Glaser BM. Retinal microvessel extracellular matrix: An immunofluorescent study. Invest Ophthalmol Vis Sci. 1986;27:194-203.
14. Das A, Frank RN, Zhang NL, Turczyn TJ. Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch's membrane. Arch Ophthalmol. 1990;108:421-429.
15. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: Phenomenon with a memory. Proc Natl Acad Sci USA. 1990;87:404-408.
16. Magnuson VL, Young M, Schattenberg DG, et al. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J Biol Chem. 1991;266:14654-14662.
17. French-Constant C, Van De Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol. 1989;109:903-914.
18. Takasaki I, Chobaian AV, Mamuya WS, Brecher P. Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension. 1992;20:20-25.
19. Burke EM, Danner DB. Changes in fibronectin mRNA splicing with in vitro passage. Biochem Biophys Res Comm. 1991;178:620-624.
20. Balza E, Borsi L, Allemanni G, Zardi L. Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett. 1988;228:42-44.
21. Madri JA, Pratt BM, Yannarello-Brown J. Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol. 1988;132:18-27.
22. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube, and vascular development in mouse embryos lacking fibronectin. Development. 1993;119:1079-1091.
23. Roth, T, Podestá F, Stepp MA, Boeri D, Lorenzi M. Integrin overexpression induced by high glucose and by human diabetes: Potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci USA. 1993;90:9640-9644.
24. Boeri D, Cagliero E, Podestá F, Lorenzi M. Vascular wall von Willebrand factor in human diabetic retinopathy. Invest Ophthalmol Vis Sci. 1994;35:600-607.
25. Kuwabara T, Cogan DG. Studies of retinal vascular patterns: I: Normal architecture. Arch Ophthalmol. 1960;64:904-911.
26. Murphy LD, Herzog CE, Rudnick JB, Fojo AT, Bates SE. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry. 1990;29:10351-10356.
27. Horikoshi T, Danenberg KD, Stadibauer THW, et al. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res. 1992;52:108-116.
28. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA. 1985;82:6133-6137.
29. Oldberg A, Linney E, Ruoslahti E. Molecular cloning and nucleotide sequence of a cDNA clone coding for the cell attachment domain in human fibronectin. J Biol Chem. 1983;258:10193-10196.
30. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28:506-514.
31. Courtoy PJ, Boyles J. Fibronectin in the microvasculature: Localization in the pericyte-endothelial interstitium. J Ultrastruct Res. 1983;83:258-273.
32. Kornblihtt AR, Vibe-Pedersen K, Baralle FE. Human fibronectin: Cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucl Acids Res. 1984;12:5853-5868.
33. Kohno T, Sorgente N, Goodnight R, Ryan SJ. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci. 1987;28:515-521.
34. Aiello LP, Robinson GS, Lin YW, Nishio Y, King GL. Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci USA. 1994;91:6231-6235.
35. Carlson EC, Bjork NJ. SEM and TEM analyses of isolated human retinal microvessel basement membranes in diabetic retinopathy. Anat Rec. 1990;226: 295-306.
36. Robison WG, Nagata M, Tillis TN, Laver N, Kinoshita JH. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Invest Ophthalmol Vis Sci. 1989;30:2293-2299.
37. DiMilla PA, Stone JA, Quinn JA, Albelda SM, Lauffenburger DA. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol. 1993;122:729-737.